Atlas Trials

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Clinical trial NCT00274638 · COMPLETED

Trial details

NCT number
NCT00274638
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypertension
Start date
2002-07-01
Primary completion
2003-07-01
Enrollment
805

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.